Treatment of Vitiligo With Topical Janus Kinase Inhibitor Ruxolitinib
Document Type
Abstract
Publication Date
May 2017
Journal Title
Journal of Investigative Dermatology
Department
Dermatology
Recommended Citation
Rothstein, B., Joshipura, D., Saraiya, A., Abdat, R., Ashkar, H., Turkowski, Y., Sheth, V., Huang, V., Au, S., Kachuk, C., Dumont, N., Gottlieb, A., & Rosmarin, D. (2017). Treatment of Vitiligo With Topical Janus Kinase Inhibitor Ruxolitinib. Journal of Investigative Dermatology, 137 (5 Suppl 1), S132. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/126
COinS
